CACNA1C risk variant is associated with increased amygdala volume

Area of Science:

• Neurogenetics
• Psychiatric Disorders
• Neuroimaging

Background:

• Genome-wide association studies identify L-type calcium channel gene variations, including rs1006737 in CACNA1C, as risk factors for psychosis.
• This specific polymorphism is linked to schizophrenia, bipolar disorder, and intermediate phenotypes, suggesting a genetic basis for psychosis.
• CACNA1C has been implicated in amygdala structure and function, a key limbic region.

Purpose of the Study:

• To investigate the association between the rs1006737 polymorphism in CACNA1C and amygdala volume in healthy individuals.
• To explore whether genetic variation in CACNA1C influences neurobiological intermediate phenotypes relevant to psychosis risk.

Main Methods:

• Genotyping of the rs1006737 single nucleotide polymorphism in CACNA1C.
• Magnetic resonance imaging (MRI) to measure amygdala volume.
• Statistical analysis correlating genotype with amygdala volume in a cohort of 258 healthy participants.

Main Results:

• The risk allele (A) of rs1006737 in CACNA1C was significantly associated with increased amygdala volume in healthy individuals.
• This finding provides a direct link between a psychosis risk genetic variant and a specific neuroanatomical alteration.

Conclusions:

• Genetic variation in CACNA1C may confer risk to psychosis through its effects on limbic structures, specifically the amygdala.
• The amygdala may serve as a crucial intermediate phenotype for understanding the neurobiological mechanisms underlying genetic risk for psychosis.
• Further research on CACNA1C and intermediate phenotypes is warranted to elucidate the precise pathways linking genetic variation to psychotic disorders.